Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Finasteride reduces hair growth and is safe for women with excessive hair.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

A natural steroid in the body may protect against eye damage in glaucoma.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Early hair loss may indicate prostate issues.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.